Experienced in Age-Related Macular Degeneration (ARMD)

Vinodh Kakkassery

Ratzeburger Allee 160, 
Luebeck, SH, DE 
Experienced in Age-Related Macular Degeneration (ARMD)
Ratzeburger Allee 160, 
Luebeck, SH, DE 
OverviewLocationsClinical Research

Overview

Vinodh Kakkassery practices in Luebeck, Germany. Dr. Kakkassery is rated as an Experienced expert by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). Their top areas of expertise are Basal Cell Skin Cancer, Uveal Melanoma, Retinoblastoma, Vitrectomy, and Tissue Biopsy.

Their clinical research consists of co-authoring 126 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 4 articles in the study of Age-Related Macular Degeneration (ARMD).

Locations

Ratzeburger Allee 160, Luebeck, SH 23562, Germany
Other Locations
Ratzeburger Allee 160, Luebeck, SH 23538, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A NON-COMMERCIAL, MULTICENTER, RANDOMIZED, TWO-ARMED, OPEN-LABEL PHASE III STUDY TO EVALUATE THE ADJUVANT VACCINATION WITH TUMOR RNA-LOADED AUTOLOGOUS DENDRITIC CELLS VERSUS OBSERVATION OF PATIENTS WITH RESECTED MONOSOMY 3 UVEAL MELANOMA
A NON-COMMERCIAL, MULTICENTER, RANDOMIZED, TWO-ARMED, OPEN-LABEL PHASE III STUDY TO EVALUATE THE ADJUVANT VACCINATION WITH TUMOR RNA-LOADED AUTOLOGOUS DENDRITIC CELLS VERSUS OBSERVATION OF PATIENTS WITH RESECTED MONOSOMY 3 UVEAL MELANOMA
Enrollment Status: Completed
Publish Date: January 28, 2026
Intervention Type: Biological
Study Drug: Autologous Dendritic Cells Loaded with Autologous Tumor RNA
Study Phase: Phase 3

126 Total Publications

The DECODE VRL study-Multicenter implementation and clinical validation of standardized innovative molecular biological diagnostics for vitreoretinal lymphoma
The DECODE VRL study-Multicenter implementation and clinical validation of standardized innovative molecular biological diagnostics for vitreoretinal lymphoma
Journal: Die Ophthalmologie
Published: August 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kakkassery's expertise for a condition
ConditionClose
    View All 27 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile